Clinical trial: Who, what, where, why? | endTB

Skip to main content

Search

Main navigation

About
Countries
- Armenia
- Bangladesh
- Belarus
- DPRK
- Ethiopia
- Georgia
- Haiti
- Indonesia
- Kazakhstan
- Kenya
- Kyrgyzstan
- Lesotho
- Myanmar
- Pakistan
- Peru
- South Africa
- Vietnam
Toolkit
News & stories
Resources

December 8, 2016

Teaser

Wondering what our clinical trial aims to achieve? Watch this MSF-produced video to find out more:

Latest news

WHO rapid communication

endTB Statement on WHO Rapid Communication on key changes to the treatment of drug-resistant tuberculosis

Atul Loke/Panos Pictures

[Media] Ending TB by 2025 needs more clinical research on drug resistance

MDR-TB Treatment

GOOD SAFETY AND EFFICACY OF ANTI-TUBERCULOSIS TREATMENTS CONTAINING BEDAQUILINE OR DELAMANID, ADMINISTERED ALONE OR CONCOMITANTLY

Photos: Bithin Das / MDR-TB Treatment

October 18, 2021

Innovative Worldwide Clinical Trial for Multidrug-Resistant Tuberculosis Completes Enrollment

Photo Atul Loke/Panos Pictures

October 14, 2020

India: a new country for the endTB clinical trials

MDR-TB Treeatment preparation in the National Centre for Tuberculosis and Lung Disease in Tbilisi

September 10, 2020

New publication of the results from the endTB Observational Study

PIH

UNITAID

Footer menu

Contact
Sign in